Literature DB >> 35762435

[Metabolomic changes of neonatal sepsis: an exploratory clinical study].

Ping Tong1, Fu-Rong Huang, Jun Xu, Zi-Qi Wu, Xing Hu, Ming Ling, Die Wang, Bu-Fei Wu, Du-Jiao Yang, Ai-Min Zhang.   

Abstract

OBJECTIVES: To study the metabolic mechanism of neonatal sepsis at different stages by analyzing the metabolic pathways involving the serum metabolites with significant differences in neonates with sepsis at different time points after admission.
METHODS: A total of 20 neonates with sepsis who were hospitalized in the Department of Neonatology, Hunan Provincial People's Hospital, from January 1, 2019 to January 1, 2020 were enrolled as the sepsis group. Venous blood samples were collected on days 1, 4, and 7 after admission. Ten healthy neonates who underwent physical examination during the same period were enrolled as the control group. Ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry was used for the metabonomic analysis of serum samples to investigate the change in metabolomics in neonates with sepsis at different time points.
RESULTS: On day 1 after admission, the differentially expressed serum metabolites between the sepsis and control groups were mainly involved in the biosynthesis of terpenoid skeleton. For the sepsis group, the differentially expressed serum metabolites between days 1 and 4 after admission were mainly involved in pyruvate metabolism, and those between days 4 and 7 after admission were mainly involved in the metabolism of cysteine and methionine. The differentially expressed serum metabolites between days 1 and 7 after admission were mainly involved in ascorbic acid metabolism.
CONCLUSIONS: The metabolic mechanism of serum metabolites varies at different stages in neonates with sepsis and is mainly associated with terpenoid skeleton biosynthesis, pyruvate metabolism, cysteine/methionine metabolism, and ascorbic acid metabolism.

Entities:  

Keywords:  Metabolomics; Neonatal sepsis; Neonate

Mesh:

Substances:

Year:  2022        PMID: 35762435      PMCID: PMC9250401          DOI: 10.7499/j.issn.1008-8830.2112020

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  31 in total

Review 1.  Traditional antimalarials and the development of novel antimalarial drugs.

Authors:  Colin W Wright
Journal:  J Ethnopharmacol       Date:  2005-08-22       Impact factor: 4.360

2.  A metabonomic approach to early prognostic evaluation of experimental sepsis by (1)H NMR and pattern recognition.

Authors:  Zhong-ying Lin; Ping-bo Xu; Shi-kai Yan; Hai-bing Meng; Gen-jin Yang; Wei-xing Dai; Xin-ru Liu; Jin-bao Li; Xiao-ming Deng; Wei-dong Zhang
Journal:  NMR Biomed       Date:  2009-07       Impact factor: 4.044

3.  Production of bioactive ginsenoside compound K in metabolically engineered yeast.

Authors:  Xing Yan; Yun Fan; Wei Wei; Pingping Wang; Qunfang Liu; Yongjun Wei; Lei Zhang; Guoping Zhao; Jianmin Yue; Zhihua Zhou
Journal:  Cell Res       Date:  2014-03-07       Impact factor: 25.617

4.  The effects of high-dose vitamin C therapy on postburn lipid peroxidation.

Authors:  T Matsuda; H Tanaka; H Yuasa; R Forrest; H Matsuda; M Hanumadass; H Reyes
Journal:  J Burn Care Rehabil       Date:  1993 Nov-Dec

5.  Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo.

Authors:  A K Salahudeen; E C Clark; K A Nath
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis.

Authors:  Said Sami Erdem; Fatma Hümeyra Yerlikaya; Hümeyra Çiçekler; Mehmet Gül
Journal:  Clin Chem Lab Med       Date:  2012-02-14       Impact factor: 3.694

7.  Methylation metabolism in sepsis and systemic inflammatory response syndrome.

Authors:  Alexander Semmler; Jean-Christophe Prost; Yvo Smulders; Desiree Smith; Henk Blom; Laurent Bigler; Michael Linnebank
Journal:  Scand J Clin Lab Invest       Date:  2013-04-08       Impact factor: 1.713

8.  Ethyl pyruvate protects against sepsis by regulating energy metabolism.

Authors:  Hongjun Kang; Zhi Mao; Yan Zhao; Ting Yin; Qing Song; Liang Pan; Xin Hu; Jie Hu; Feihu Zhou
Journal:  Ther Clin Risk Manag       Date:  2016-02-23       Impact factor: 2.423

Review 9.  Efficacy of Terpenoid in Attenuating Aortic Atherosclerosis in Apolipoprotein-E Deficient Mice: A Meta-Analysis of Animal Studies.

Authors:  Han Liu; Yang Zhang; Siqiao Sun; Shuai Wang
Journal:  Biomed Res Int       Date:  2019-07-17       Impact factor: 3.411

10.  Optimum Inhibition of Amphotericin-B-Resistant Candida albicans Strain in Single- and Mixed-Species Biofilms by Candida and Non-Candida Terpenoids.

Authors:  Hidaya F Z Touil; Kebir Boucherit; Zahia Boucherit-Otmani; Ghalia Kohder; Mohamed Madkour; Sameh S M Soliman
Journal:  Biomolecules       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.